---
$id: https://graph.org.ai/products/commodity/51282105
$type: Product
source: UNSPSC
code: "51282105"
title: "Latamoxef or moxalactam"
class: "51282100"
classTitle: "Beta-lactams"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Latamoxef or moxalactam

**UNSPSC Code**: 51282105
**Class**: [Beta-lactams](Beta-lactams.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a beta-lactam antibiotic with the molecular formula C20H20N6O9S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VUF6C936Z3, chemically known as 7-((carboxy(4-hydroxyphenyl)acetyl)amino)-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-5-oxa-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid (6r-(6alpha,7alpha,7(s*)))- but generally known as latamoxef, which bears US NIH Compound Identifier 47499. European Medicines Agency schedules Latamoxef in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08408MIG. The term LATAMOXEF is an International Non-Proprietary Name. World Health Organization schedules latamoxef in its Anatomical Therapeutic Chemical (ATC) Classification. LATAMOXEF is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Latamoxef or moxalactam bears US NLM identifiers UMLS ID C0026651 and NCI Concept Code C670. SMILES: S(CC1=C(N2C(OC1)C(OC)(NC(=O)C(C1CCC(O)CC1)C(=O)O)C2=O)C(=O)O)C1N(NNN1)C.

